Novartis, CH0012005267

Novartis stock pre-market at EUR 136.79: medicines company

Published on 10/22/2026 at 08:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Novartis describes its work as reimagining medicine to improve and extend people’s lives. At Lang & Schwarz the stock trades pre-market at EUR 136.79 on October 22, 2026.

Business model and market context

Novartis describes its work as reimagining medicine to improve and extend people’s lives.
Switzerland’s SMI is the benchmark for the home market on October 22, 2026.
Novartis stock trades pre-market at EUR 136.79 at 8:49 a.m. CEST at Lang & Schwarz on October 22, 2026.

Futuristisches Forschungsgebäude mit ovaler Glasfassade und Spiegelteich im Vordergrund — Novartis AG CH0012005267 – Futuristisches Forschungsgebäude mit ovaler Glasfassade, Spiegelteich und Grünanlagen, Illustration mit AI erstellt.

Novartis describes its work as reimagining medicine to improve and extend people’s lives, according to its investor-relations page. Novartis stock trades pre-market at EUR 136.79 at 8:49 a.m. CEST at Lang & Schwarz on October 22, 2026.

Pre-market trading range

The bid was EUR 135.84 and the ask EUR 137.74. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Novartis stock.

Business and market context

Novartis develops medicines and uses research to support patient access, as described by the company in its investor materials. Switzerland’s SMI is the benchmark index for the company’s home market.

Market context: Market report SMI.

More news and analysis on Novartis stock